{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P01584",
      "entity_text" : "IL-1beta",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04795",
      "entity_text" : "Evo",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The results revealed that Evo dose-dependently reduced the protein and mRNA expression levels of tumor necrosis factor (TNF)-alpha, interleukin (IL) -6 and IL-1beta, and inhibited the levels of phosphorylated (p-) inhibitor of NF-kappaBalpha, p-extracellular signal regulated kinase, p-c-Jun N-terminal kinase and p-p38, and decreased the nuclear trans-location of NF-kappaB / p65 in BEAS-2B cells infected with MSSA.",
  "reading_complete" : "2020-08-03T18:03:27Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T18:02:34Z",
  "trigger" : "reduced",
  "evidence" : [ "Evo dose-dependently reduced the protein and mRNA expression levels of tumor necrosis factor (TNF)-alpha, interleukin (IL)-6 and IL-1beta" ],
  "pmc_id" : "6202108",
  "score" : 0
}